Population-based SEER trend analysis of overall and cancer-specific survival in 5138 patients with gastrointestinal stromal tumor.

作者: Ulrich Güller , Ignazio Tarantino , Thomas Cerny , Bruno M. Schmied , Rene Warschkow

DOI: 10.1186/S12885-015-1554-9

关键词:

摘要: … Patients with other SEER reportable cancers were excluded unless the GIST was the first diagnosed malignancy (NAACCR Item 380) in order to use the cancer-specific survival. …

参考文章(24)
Phyllis A. Wingo, Patricia M. Jamison, Robert A. Hiatt, Hannah K. Weir, Paul M. Gargiullo, Mary Hutton, Nancy C. Lee, H. Irene Hall, Building the infrastructure for nationwide cancer surveillance and control--a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes & Control. ,vol. 14, pp. 175- 193 ,(2003) , 10.1023/A:1023002322935
Merce Jorda, Leonidas G. Koniaris, Eduardo A. Perez, Alan S. Livingstone, Dido Franceschi, Caio Rocha-Lima, David J. Lee, Nicole Hodgson, Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors. Journal of The American College of Surgeons. ,vol. 202, pp. 623- 629 ,(2006) , 10.1016/J.JAMCOLLSURG.2006.01.002
Heikki Joensuu, Christopher Fletcher, Sasa Dimitrijevic, Sandra Silberman, Peter Roberts, George Demetri, Management of malignant gastrointestinal stromal tumours. Lancet Oncology. ,vol. 3, pp. 655- 664 ,(2002) , 10.1016/S1470-2045(02)00899-9
PATRICIA M. GRAMBSCH, TERRY M. THERNEAU, Proportional hazards tests and diagnostics based on weighted residuals Biometrika. ,vol. 81, pp. 515- 526 ,(1994) , 10.1093/BIOMET/81.3.515
Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, Jörg T. Hartmann, Daniel Pink, Jochen Schütte, Giuliano Ramadori, Peter Hohenberger, Justus Duyster, Salah-Eddin Al-Batran, Marcus Schlemmer, Sebastian Bauer, Eva Wardelmann, Maarit Sarlomo-Rikala, Bengt Nilsson, Harri Sihto, Odd R. Monge, Petri Bono, Raija Kallio, Aki Vehtari, Mika Leinonen, Thor Alvegård, Peter Reichardt, One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor JAMA. ,vol. 307, pp. 1265- 1272 ,(2012) , 10.1001/JAMA.2012.347
Christopher D.M. Fletcher, Jules J. Berman, Christopher Corless, Fred Gorstein, Jerzy Lasota, B.Jack Longley, Markku Miettinen, Timothy J. O'Leary, Helen Remotti, Brian P. Rubin, Barry Shmookler, Leslie H. Sobin, Sharon W. Weiss, Diagnosis of gastrointestinal stromal tumors: A consensus approach Human Pathology. ,vol. 33, pp. 459- 465 ,(2002) , 10.1053/HUPA.2002.123545
Thomas Tran, Jessica A. Davila, Hashem B. El-Serag, The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. The American Journal of Gastroenterology. ,vol. 100, pp. 162- 168 ,(2005) , 10.1111/J.1572-0241.2005.40709.X
William S. Cleveland, Susan J. Devlin, Locally Weighted Regression: An Approach to Regression Analysis by Local Fitting Journal of the American Statistical Association. ,vol. 83, pp. 596- 610 ,(1988) , 10.1080/01621459.1988.10478639
J. Rubió-Casadevall, J. L. Borràs, C. Carmona, A. Ameijide, G. Osca, L. Vilardell, A. Izquierdo, J. Galceran, R. Marcos-Gragera, Temporal trends of incidence and survival of sarcoma of digestive tract including Gastrointestinal Stromal Tumours (GIST) in two areas of the north-east of Spain in the period 1981-2005: a population-based study Clinical & Translational Oncology. ,vol. 16, pp. 660- 667 ,(2014) , 10.1007/S12094-013-1131-0
Heikki Joensuu, Aki Vehtari, Jaakko Riihimäki, Toshirou Nishida, Sonja E Steigen, Peter Brabec, Lukas Plank, Bengt Nilsson, Claudia Cirilli, Chiara Braconi, Andrea Bordoni, Magnus K Magnusson, Zdenek Linke, Jozef Sufliarsky, Massimo Federico, Jon G Jonasson, Angelo Paolo Dei Tos, Piotr Rutkowski, None, Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts Lancet Oncology. ,vol. 13, pp. 265- 274 ,(2012) , 10.1016/S1470-2045(11)70299-6